Edwards Lifesciences Corp. Stock Climbs 3.1%, Outperforms Market

Dow Jones
Aug 21

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. advanced 3.1% to $81.39 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the S&P 500 Index falling 0.2% to 6,395.78.

This was the stock's sixth consecutive day of gains.

Edwards Lifesciences Corp. closed 1.9% below its 52-week high of $83.00, which the company reached on July 25th.

The stock demonstrated a mixed performance when compared to some of its competitors, as Abbott Laboratories rose 0.9% to $132.44, Medtronic PLC rose 3.7% to $93.22, and Stryker Corp. rose 0.49% to $391.87.

Trading volume totaled 5.0 million, compared to the 50-day average of 4.2 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

August 20, 2025 16:35 ET (20:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10